We are live on ! Find out more
AGC

Angelo Gordon & Co Portfolio holdings

AUM $1.06B
1-Year Est. Return 47.95%
This Fund
S&P 500
This Quarter Est. Return
+27%
1 Year Est. Return
+47.95%
3 Year Est. Return
+90.06%
5 Year Est. Return
+125.11%
10 Year Est. Return
+345.29%
AUM
$818M
AUM Growth
+$66.2M
Cap. Flow
-$19.6M
Cap. Flow %
-2.4%
Top 10 Hldgs %
56.91%
Holding
76
New
15
Increased
7
Reduced
9
Closed
13
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKX
51
DELISTED
Skechers
SKX
-160,000
Closed -$10.1M
SPTN
52
DELISTED
SpartanNash
SPTN
-150,000
Closed -$3.97M
TGI
53
DELISTED
Triumph Group
TGI
-123,370
Closed -$3.18M

Similar funds

Angelo Gordon & Co's Q3 2025 Portfolio in Review

As of Q3 2025, Angelo Gordon & Co held 76 positions worth $818M, up 8.8% from $751M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Angelo Gordon & Co's Q3 2025 filing shows 15 new, 7 increased, 9 reduced and 13 closed positions. Its largest new stake was Verona Pharma: 145,000 shares worth $15.5M. The largest sale was NextEra Energy, Inc. 6.926% Corporate Units, an estimated $17.9M.

By sector, the portfolio is most concentrated in Real Estate at 15% of assets, up from 5% a quarter earlier, followed by Industrials and Healthcare.

  • Angelo Gordon & Co's largest Q3 2025 buy was Verona Pharma: 145,000 shares worth $15.5M.
  • Angelo Gordon & Co added most to TPG Mortgage Investment Trust in Q3 2025, an estimated $15.4M increase.
  • Angelo Gordon & Co's biggest Q3 2025 reduction was Hewlett Packard Enterprise 7.625% Series C Preferred Stock, cutting an estimated $4.71M.
  • Angelo Gordon & Co fully exited NextEra Energy, Inc. 6.926% Corporate Units in Q3 2025, selling an estimated $17.9M.
  • Angelo Gordon & Co's ten largest holdings make up 57% of its $818M portfolio in Q3 2025.
  • Angelo Gordon & Co opened 15 new positions and closed 13 in Q3 2025.
  • Angelo Gordon & Co's portfolio value rose 8.8% quarter-over-quarter to $818M.

Based on Angelo Gordon & Co's 13F filing for Q3 2025, filed 14 Nov 2025.